Clinical Evaluation of Florbetapir F 18 (18F-AV-45)

NCT01518374 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

1768

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer Disease
Mild Cognitive Impairment
Neurodegenerative Diseases

Interventions

DRUG: Florbetapir F 18

Sponsor

Avid Radiopharmaceuticals